Thus far, only case reports have described attempted treatment with IFNγ supplementation, rituximab, or cyclophosphamide combined with prednisone in patients with anti-IFNγ auto-antibodies and a double infection with TB and NTM with both positive and negative outcomes [9,18,19,20]. Here, IFNG is linked to tuberculosis.